|
RPP38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.513890E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.590030E-02 |
| Normal-vs-Stage2 |
6.261400E-01 |
| Normal-vs-Stage3 |
1.800430E-01 |
| Normal-vs-Stage4 |
4.042600E-03 |
| Stage1-vs-Stage2 |
7.300300E-03 |
| Stage1-vs-Stage3 |
8.649200E-01 |
| Stage1-vs-Stage4 |
3.650400E-01 |
| Stage2-vs-Stage3 |
1.142220E-01 |
| Stage2-vs-Stage4 |
2.223600E-03 |
| Stage3-vs-Stage4 |
4.255800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.820410E-01 |
| Normal-vs-AfricanAmerican |
3.073700E-02 |
| Normal-vs-Asian |
1.024170E-01 |
| Caucasian-vs-AfricanAmerican |
8.761800E-02 |
| Caucasian-vs-Asian |
1.392970E-01 |
| AfricanAmerican-vs-Asian |
5.348600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.297600E-02 |
| Normal-vs-Female |
3.680500E-03 |
| Male-vs-Female |
1.501550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.677400E-01 |
| Normal-vs-Extreme_Weight |
1.480820E-01 |
| Normal-vs-Obese |
2.922400E-02 |
| Normal-vs-Extreme_Obese |
7.713000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.214600E-01 |
| Normal_Weight-vs-Obese |
3.889400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.766400E-01 |
| Extreme_Weight-vs-Obese |
3.592800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.217600E-01 |
| Obese-vs-Extreme_Obese |
1.714750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.075200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.223200E-03 |
| Normal-vs-Age(61-80Yrs) |
3.643200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.970200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.197810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.571600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.559100E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.690400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.883540E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.718000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.556200E-03 |
| Normal-VS-Type2 PRCC |
5.537600E-01 |
| Normal-VS-KIRP CIMP |
1.799610E-03 |
| Normal-VS-Unclassified PRCC |
6.476200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.858530E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.508800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.269800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.860000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.009600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.177600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.350400E-01 |
| Normal-vs-N1 |
6.859900E-02 |
| Normal-vs-N2 |
8.581000E-01 |
| N0-vs-N1 |
7.303700E-02 |
| N0-vs-N2 |
8.867200E-01 |
| N1-vs-N2 |
4.289600E-01 |
|
|
